Adenoma Clinical Trial
Official title:
Narrow Band Versus Conventional Endoscopic Imaging for Screening Colonoscopy in a Private Practice Setting - A Large Prospective Randomized Trial
Narrow Band Imaging (NBI) with high-definition (HDTV) visualization has been implemented
into GI endoscopy with the purpose to better highlight endoluminal pathological structures
by improving their contrast. Previous studies from referral centers could not show
significant differences in terms of colonoscopic adenoma detection rate, but either very
high adenoma rates or some numerical differences suggested that some benefit may exist which
may become evident with average adenoma rates and/or large case numbers.
In a prospective randomized trial performed exclusively in a multicenter private practice
setting involving 6 examiners with substantial life-time experience (>10.000 colonoscopies)
1200 patients will undergo HDTV screening colonoscopy with either NBI or conventional
imaging technique on instrument withdrawal. Primary outcome measure is the adenoma detection
rate (ADR; i.e. number of adenomas per patient).
in 5 private practices with 6 examiners, consecutive asymptomatic persons willing to undergo
screening colonoscopy will be asked to participate in this randomized study.
After introduction of the colonoscope into the cecum, patients will be randomized into
withdrawal with either the NBI mode or conventional imaging by using wide-angle colonoscopes
with HDTV imaging (Olympus Corp., Hamburg, Germany) in both groups. Randomization lists will
be used for group allocation in each individual practice. In the NBI group, switching back
to conventional imaging, and the number of occasions for switching back and the reasons for
it are documented in this group.
Patients bowel preparation consists mostly of polyethylene glycol lavage with 4-5 liters
until clear rectal fluid is evacuated. All examiners shall take special care to wash and
clean the entire large bowel during instrument introduction and withdrawal, in order to
provide optimal imaging conditions.
The following parameters are documented:
- Age and sex of the patient
- Type and dosage of sedation
- Examination time, both for instrument introduction and withdrawal
- Polyp characteristics: size (measured by open forceps or snare), shape
(pedunculated/elevated, sessile/flat, and location
- Polyp histology after removal using snare polypectomy or forceps removal (for polyps <
3 mm), or biopsy if there are contraindications
- Other lesions found such as cancers, diverticula, inflammatory lesions etc. The main
outcome parameter is the adenoma detection rate (number of polyps/number of patients
examined) in the two groups.
Secondary outcome measures include analysis of the total number of polyps, flat/sessile
adenomas, small adenomas (< 1 cm), hyperplastic polyps with size determination and
right-sided versus left-sided polyp location in both groups.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
| Recruiting |
NCT02545699 -
Prospective Trial to Compare ADR of G-EYE™ Colonoscopy With Standard Colonoscopy
|
N/A | |
| Completed |
NCT01802008 -
Comparison of Adenoma Detection Miss Rates at Colonoscopy Associated With Different Withdrawal Times
|
N/A | |
| Recruiting |
NCT01211132 -
Cap Assisted Colonoscopy for the Detection of Colon Polyps
|
N/A | |
| Completed |
NCT04287335 -
Multitarget Stool FIT-DNA Study for Colorectal Cancer Early Screening in China
|
||
| Not yet recruiting |
NCT06398418 -
R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT05362344 -
Colorectal Cancer Screening in Cystic Fibrosis
|
||
| Completed |
NCT03268200 -
The Effect of Segmental Re-examination of Colon for Adenoma Detection in Colonoscopy
|
N/A | |
| Recruiting |
NCT04591145 -
Multi-center Validation of a Deep Learning Based Bowel Preparation Evaluation System
|
||
| Completed |
NCT02978664 -
The Impact of Distraction on Adenoma Detection Rate
|
N/A | |
| Completed |
NCT00018551 -
Chemoprevention With Folic Acid
|
Phase 2 | |
| Recruiting |
NCT05594576 -
Comparison of the ENDOCUFF VISION® Endoscopy Cap Coupled With GI GENIUS™ Artificial Intelligence Compared to Each Device Alone in Improving Colonic Adenoma Detection Rate During Colonoscopy
|
N/A | |
| Not yet recruiting |
NCT04135716 -
A Multicenter Study Evaluating the Effectiveness of Endo.Angel in Improving the Quality of Colonoscopy
|
N/A | |
| Recruiting |
NCT02288962 -
Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas
|
Phase 3 | |
| Recruiting |
NCT02552017 -
Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities
|
N/A | |
| Completed |
NCT02066064 -
G-Eye Advanced Colonoscopy For Increased Polyp Detection Rate-randomized Tandem Study With Different Endoscopist
|
N/A | |
| Completed |
NCT01749722 -
Safety and Efficacy of the NaviAid™ G-Eye System During Colonoscopy
|
N/A | |
| Completed |
NCT01485133 -
Water Method Colonoscopy in Patients With Prior Surgery
|
N/A | |
| Withdrawn |
NCT01546246 -
Water Method in Patients With Incomplete Colonoscopy
|
N/A | |
| Withdrawn |
NCT01546259 -
Water Method in Low-body Mass Index (BMI) Female Patients With Unsedated Colonoscopy
|
N/A |